⌘K

Login Start Free

Home/Filings/4/0000950170-24-074996

4//SEC Filing

KAPLAN GILLA 4

Accession 0000950170-24-074996

CIK 0001863127other

View on SEC.gov Company Profile

Filed

Jun 17, 8:00 PM ET

Accepted

Jun 18, 5:01 PM ET

Size

6.5 KB

Accession

0000950170-24-074996

Insider Transaction Report

Form 4

Period: 2024-06-13

Tyra Biosciences, Inc.TYRA

Director

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2024-06-13−61,392→ 0 total
Exercise: $0.61Exp: 2030-01-26→ Common Stock (61,392 underlying)
Exercise/Conversion
Common Stock
2024-06-13$0.61/sh+61,392$37,449→ 89,623 total

Footnotes (1)

[F1]Fully vested.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1

filerCIK 0001247024

Filing Metadata

Form type: 4
Filed: Jun 17, 8:00 PM ET
Accepted: Jun 18, 5:01 PM ET
Size: 6.5 KB

View on SEC.gov